GetPortalImpactFactorByIdResp(projectId=1, id=20a916406, cover=https://img.medsci.cn/20231103/1698992275390_1614372.jpg, fullname=Therapeutic Advances in Drug Safety, abbr=THER ADV DRUG SAF, pyear=2010, frequence=C, articleNumbers=320, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2042-0986, greenSci=https://www.greensci.net/search?kw=2042-0986, scijournal=https://www.scijournal.org/impact-factor-of-THER-ADV-DRUG-SAF.shtml, medsciHotlightString=null, medsciHotlightRealtime=1.939, medsciHotlight=0.967, medsciHotlight5year=0.487333, citescore=6.3, hIndex=32, impactFactor=4.4, orgnization=SAGE Publications Ltd, orgnizationUrl=https://uk.sagepub.com/en-gb/asi/home?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, country=United Kingdom, countryCn=英国, isOa=1, isOaString=是, sciScie=Clarivate Analytics: Current Contents - Clinical Medicine Clarivate Analytics: Science Citation Index Expanded (SCIE) Directory of Open Access Journals (DOAJ) ProQuest PubMed Central (PMC) Scopus, bigclassCas=null, smallclassCas=医学 3 区, website=https://journals.sagepub.com/home/TAW?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, websiteHits=47, guideForAuthor=https://journals.sagepub.com/author-instructions/TAW?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, guideForAuthorHits=28, submitWebsite=https://mc.manuscriptcentral.com/tads?utm_source=wechat&utm_medium=SAGE_social&utm_campaign=WeChat_MedSci1103, submitWebsiteHits=24, content=<p>该刊是经过同行评审的开放获取期刊，出版患者安全用药相关的前沿探索和创新研究。该期刊重点关注临床和药理学领域，面向全球药物安全领域的临床医生和研究人员，快速传播该领域的最新研究和观点。</p>, totalCites=1410, brief=THER ADV DRUG SAF杂志暂不明确行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=药理学" >药理学</a></strong>”子行业的优秀级杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=THER ADV DRUG SAF杂志级别还可以，但是相对来说，比较冷门，关注人数偏少，有些可能是国内不太熟悉，但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿，稿源可能未必丰富，发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=20a916406'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=null, citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2020, citescore=6.3)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=0.667), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=0.795), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=0.947), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=1.266), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=1.939)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2042-0986[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Therapeutic Advances in Drug Safety[ta], article_number=31, article_number_cn=1, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)